Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Scientists turn the tables on cancer with new immunotherapy targeton May 10, 2020 at 5:19 pm
One of the best weapons against cancer might have been inside us all along – our own immune systems. Immunotherapy involves supercharging the immune system to better root out cancer from its hiding ...
- Immunotherapy improves outcome in high-risk, HER2-negative breast canceron May 8, 2020 at 1:07 pm
(Reuters Health) - Adding the immune-checkpoint inhibitor durvalumab and the PARP inhibitor olaparib to standard neoadjuvant chemotherapy may improve outcome in women with high-risk, HER2-negative ...
- Cancer Immunotherapy Market Will Grow At A CAGR of 7.5% During Forecast Period 2018-2027 (Impact Analysis of COVID-19)on May 8, 2020 at 8:57 am
Market Trends in Global Cancer Immunotherapy Market Roche Pharma and India's third-largest drug maker Cipla tied up ...
- A new plant-based system for the mass production of allergens for immunotherapyon May 8, 2020 at 6:55 am
Allergies can significantly affect health and quality of life. While allergen immunotherapy provides long-lasting therapeutic relief to people suffering from environmental allergies, the therapy can ...
- Immunotherapy with CAR T-cells (video)on May 8, 2020 at 6:40 am
Genetically modified immune cells attack and destroy the leukemia and blood stem cells that have a receptor (CD117) on their surface (left), while all other blood cells that do not have the receptor ...
- Ibrahim Halil Sahin, MD, on Immunotherapy for HIV Patients With Canceron May 7, 2020 at 1:14 pm
What does the study add to the literature about the role of immunotherapy in cancer patients who are also infected with HIV? Sahin: Our review of the current literature looked at patients living with ...
- IONTAS announces a new collaboration to identify novel immunotherapy targetson May 7, 2020 at 7:36 am
Antibody discovery agreement will support the development of new therapeutics for acute and chronic inflammatory syndromes.
- Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosison May 7, 2020 at 4:35 am
A long duration of treatment and emerging drug resistance pose significant challenges for global tuberculosis (TB) eradication efforts. Therefore, there is an urgent need to devel ...
- Effective combinatorial immunotherapy for penile squamous cell carcinomaon May 1, 2020 at 2:29 am
Penile squamous cell carcinoma (PSCC) is a cancer that is associated with significant mortality. Here, the authors develop a mouse model of PSCC by co-deletion of Smad4 and Apc in the ...
- Novel Immune Activator Boosts Immunotherapy Benefit in TNBCon April 30, 2020 at 10:27 am
The combination of a novel immune activator with pembrolizumab showed good activity, especially in women with disease that converted to triple negative after endocrine therapy.
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- There’s Nothing Fake About These 10 Artificial Intelligence Stocks to Buyon May 7, 2020 at 9:17 am
Stock Market News, Stock Advice & Trading Tips Artificial intelligence is one of those catchy phrases that continues to grab ...
- Fuelling Digital Pathology Advances Using Artificial Intelligenceon May 6, 2020 at 10:24 am
Reportlinker.com announces the release of the report "Fuelling Digital Pathology Advances Using Artificial Intelligence" -.
- Can Artificial Intelligence Predict Glaucoma Progression?on May 5, 2020 at 1:03 pm
A new test, supported by an artificial intelligence (AI) algorithm, can detect glaucoma progression a year and a half earlier than widely used optical coherence tomography retinal imaging technology, ...
- AI And Medical Diagnostics: Can A Smartphone App Detect Covid-19 From Speech Or A Cough?on May 5, 2020 at 12:22 pm
Researchers in several countries are working to develop a smartphone application to rapidly and accurately detect Covid-19 from spoken words, coughs, and other phrases.
- AI: A new tool for cardiac diagnosticson May 5, 2020 at 7:28 am
Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to diagnose diseases that affect the heart. Researchers at Uppsala University and heart specialists in ...
- SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligenceon May 5, 2020 at 5:30 am
Exscientia, a clinical-stage Artificial Intelligence (AI) drug-discovery company and SRI International (SRI), a research center headquartered in Menlo Park, California announced today that the ...
- Outlook on the Worldwide Sleep Apnea Therapeutic & Diagnostic Devices Industry to 2024 - Insights & Forecast with Potential Impact of COVID-19on May 5, 2020 at 4:37 am
The "Global Sleep Apnea Therapeutic & Diagnostic Devices Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report.
- Experts at trends e-discussion to analyze role of artificial intelligence in tackling Covid-19 pandemicon May 4, 2020 at 3:04 am
The latest event is part of a series of events being organized by the research center to analyze the impact of coronavirus on various spheres of the global economy ...
- Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeuticson May 1, 2020 at 2:11 am
Spatially resolved proteomic, genomic, and metabolic profiles of human cancers are now possible at the single-cell level. This perspective discusses spatial bioimaging methods to decipher the cascade ...
- Now is the time for an economic stimulus in artificial intelligence — or the US could fall behindon April 28, 2020 at 4:23 pm
Increasing research into AI will help the US economy recover from the coronavirus pandemic and better position it for the future.